论文部分内容阅读
目的探讨剖宫产术后子宫瘢痕妊娠(CSP)的诊疗方法和临床效果。方法 40例剖宫产术后子宫瘢痕妊娠患者,对其诊断方式、治疗方法及血人绒毛膜促性腺激素(β-HCG)结果等进行临床分析,对其相关的资料和诊疗信息进行回归性分析和探讨总结。结果实施治疗后,甲氨蝶呤(MTX)联合米非司酮患者的β-HCG为(1102.42±472.17)U/L,米非司酮联合米索前列醇患者的β-HCG为(1136.59±477.42)U/L,相比于治疗前结果都发生了明显下降,治疗前后结果对比,差异具有统计学意义(P<0.05)。结论实施完善的产前检查工作,及早开展诊断,对患者的有关剖宫产指征进行科学把握,对于剖宫产术后子宫瘢痕妊娠患者有很好的临床效果,能够有效降低β-HCG大小,值得在临床上推广应用。
Objective To investigate the diagnosis and treatment of uterine scar pregnancy (CSP) after cesarean section and its clinical effect. Methods 40 cases of uterine scar pregnancy after cesarean section were analyzed clinically, their diagnostic methods, treatment methods and results of blood human chorionic gonadotropin (β-HCG) were analyzed retrospectively Analysis and discussion summary. Results After treatment, β-HCG was (1102.42 ± 472.17) U / L in methotrexate (MTX) combined with mifepristone, and β-HCG in mifepristone plus misoprostol was (1136.59 ± 477.42) U / L, compared with the pre-treatment results were significantly decreased, the results before and after treatment, the difference was statistically significant (P <0.05). Conclusion The implementation of a good prenatal examination, early diagnosis, the patient’s indications for cesarean section to grasp the scientific, for patients with uterine scar pregnancy after cesarean section has a good clinical effect, can effectively reduce the size of β-HCG , It is worth to promote the clinical application.